Aus­trali­a's BioCi­na and No­vaCi­na join forces to make one CD­MO

Pri­vate in­vest­ment firm Bridgewest is com­bin­ing its Aus­tralia-based bi­o­log­ics CD­MO BioCi­na and its ster­ile in­jectable man­u­fac­tur­er No­vaCi­na in­to one com­pa­ny.

The new CD­MO will con­tin­ue …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER